 | • レポートコード：B-GIR08C1008 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、がん標的療法の世界市場について調べ、まとめました。種類別セグメントは、腫瘍抗原、臨床目的抗体開発、補体依存性細胞傷害（CDC）、シグナル伝達変化等、用途別セグメントは、等に区分しました。がん標的療法の世界市場概観、企業動向、企業別がん標的療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がん標的療法の市場概観 ・がん標的療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がん標的療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・がん標的療法の世界市場規模 ・がん標的療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・がん標的療法のアメリカ市場規模推移 ・がん標的療法のカナダ市場規模推移 ・がん標的療法のメキシコ市場規模推移 ・がん標的療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・がん標的療法のドイツ市場規模推移 ・がん標的療法のイギリス市場規模推移 ・がん標的療法のロシア市場規模推移 ・がん標的療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・がん標的療法の日本市場規模推移 ・がん標的療法の中国市場規模推移 ・がん標的療法の韓国市場規模推移 ・がん標的療法のインド市場規模推移 ・がん標的療法の東南アジア市場規模推移 ・がん標的療法の南米市場分析（ブラジル、アルゼンチン等） ・がん標的療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・がん標的療法の種類別分析/販売量、売上、市場シェア（腫瘍抗原、臨床目的抗体開発、補体依存性細胞傷害（CDC）、シグナル伝達変化） ・がん標的療法の用途別分析/市場規模（） ・がん標的療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・がん標的療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Cancer Targeted Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Targeted Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Targeted Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Targeted Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Advaxis
Bind Therapeutics
Boehringer Ingelheim
Bristol Mayer Squibb
Celldex Therapeutics
Dendreon Corporation
Eli Lily
GalaxoSmithKline
Galena Biopharma
Genetech
ImmunoCellular Therapeutics
ImmunoGen
Inovio Pharmaceuticals
Johnson & Johnson
NeoStem Oncology
NewLink Genetics
Northwest Biotherapeutics
Merck
Novartis
Peregrine Pharmaceuticals
Pfizer
Roche
Sanofi
Seattle Genetics
Teva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tumor Antigens As Targets of Antibodies
Development of Antibodies for Clinical Purposes
Complement Dependent Cytotoxicity (CDC)
Signal Transduction Changes
Market Segment by Applications, can be divided into
Hospital
Clinic
Other
Table of Contents
1 Cancer Targeted Therapy Market Overview
1.1 Product Overview and Scope of Cancer Targeted Therapy
1.2 Classification of Cancer Targeted Therapy by Types
1.2.1 Global Cancer Targeted Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Targeted Therapy Revenue Market Share by Types in 2018
1.2.3 Tumor Antigens As Targets of Antibodies
1.2.4 Development of Antibodies for Clinical Purposes
1.2.5 Complement Dependent Cytotoxicity (CDC)
1.2.6 Signal Transduction Changes
1.3 Global Cancer Targeted Therapy Market by Application
1.3.1 Global Cancer Targeted Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cancer Targeted Therapy Market by Regions
1.4.1 Global Cancer Targeted Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Targeted Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Targeted Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Targeted Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Targeted Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Targeted Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Targeted Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Advaxis
2.1.1 Business Overview
2.1.2 Cancer Targeted Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advaxis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bind Therapeutics
2.2.1 Business Overview
2.2.2 Cancer Targeted Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bind Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Cancer Targeted Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol Mayer Squibb
2.4.1 Business Overview
2.4.2 Cancer Targeted Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol Mayer Squibb Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celldex Therapeutics
2.5.1 Business Overview
2.5.2 Cancer Targeted Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celldex Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dendreon Corporation
2.6.1 Business Overview
2.6.2 Cancer Targeted Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dendreon Corporation Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lily
2.7.1 Business Overview
2.7.2 Cancer Targeted Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lily Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 GalaxoSmithKline
2.8.1 Business Overview
2.8.2 Cancer Targeted Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GalaxoSmithKline Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Galena Biopharma
2.9.1 Business Overview
2.9.2 Cancer Targeted Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Galena Biopharma Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Genetech
2.10.1 Business Overview
2.10.2 Cancer Targeted Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Genetech Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 ImmunoCellular Therapeutics
2.11.1 Business Overview
2.11.2 Cancer Targeted Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ImmunoCellular Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 ImmunoGen
2.12.1 Business Overview
2.12.2 Cancer Targeted Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 ImmunoGen Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Inovio Pharmaceuticals
2.13.1 Business Overview
2.13.2 Cancer Targeted Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Inovio Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Cancer Targeted Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.15 NeoStem Oncology
2.15.1 Business Overview
2.15.2 Cancer Targeted Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NeoStem Oncology Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.16 NewLink Genetics
2.16.1 Business Overview
2.16.2 Cancer Targeted Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 NewLink Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.17 Northwest Biotherapeutics
2.17.1 Business Overview
2.17.2 Cancer Targeted Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Northwest Biotherapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.18 Merck
2.18.1 Business Overview
2.18.2 Cancer Targeted Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Merck Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.19 Novartis
2.19.1 Business Overview
2.19.2 Cancer Targeted Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Novartis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.20 Peregrine Pharmaceuticals
2.20.1 Business Overview
2.20.2 Cancer Targeted Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Peregrine Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.21 Pfizer
2.21.1 Business Overview
2.2.2 Cancer Targeted Therapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Pfizer Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.22 Roche
2.22.1 Business Overview
2.22.2 Cancer Targeted Therapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Roche Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.23 Sanofi
2.23.1 Business Overview
2.23.2 Cancer Targeted Therapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Sanofi Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.24 Seattle Genetics
2.24.1 Business Overview
2.24.2 Cancer Targeted Therapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Seattle Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.25 Teva
2.25.1 Business Overview
2.25.2 Cancer Targeted Therapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Teva Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Targeted Therapy Market Competition, by Players
3.1 Global Cancer Targeted Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Targeted Therapy Players Market Share
3.2.2 Top 10 Cancer Targeted Therapy Players Market Share
3.3 Market Competition Trend
4 Global Cancer Targeted Therapy Market Size by Regions
4.1 Global Cancer Targeted Therapy Revenue and Market Share by Regions
4.2 North America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
5 North America Cancer Targeted Therapy Revenue by Countries
5.1 North America Cancer Targeted Therapy Revenue by Countries (2014-2019)
5.2 USA Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
6 Europe Cancer Targeted Therapy Revenue by Countries
6.1 Europe Cancer Targeted Therapy Revenue by Countries (2014-2019)
6.2 Germany Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
6.4 France Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Targeted Therapy Revenue by Countries
7.1 Asia-Pacific Cancer Targeted Therapy Revenue by Countries (2014-2019)
7.2 China Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
7.5 India Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
8 South America Cancer Targeted Therapy Revenue by Countries
8.1 South America Cancer Targeted Therapy Revenue by Countries (2014-2019)
8.2 Brazil Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Targeted Therapy by Countries
9.1 Middle East and Africa Cancer Targeted Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
10 Global Cancer Targeted Therapy Market Segment by Type
10.1 Global Cancer Targeted Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Targeted Therapy Market Forecast by Type (2019-2024)
10.3 Tumor Antigens As Targets of Antibodies Revenue Growth Rate (2014-2024)
10.4 Development of Antibodies for Clinical Purposes Revenue Growth Rate (2014-2024)
10.5 Complement Dependent Cytotoxicity (CDC) Revenue Growth Rate (2014-2024)
10.6 Signal Transduction Changes Revenue Growth Rate (2014-2024)
11 Global Cancer Targeted Therapy Market Segment by Application
11.1 Global Cancer Targeted Therapy Revenue Market Share by Application (2014-2019)
11.2 Cancer Targeted Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Cancer Targeted Therapy Market Size Forecast (2019-2024)
12.1 Global Cancer Targeted Therapy Market Size Forecast (2019-2024)
12.2 Global Cancer Targeted Therapy Market Forecast by Regions (2019-2024)
12.3 North America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
12.6 South America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Targeted Therapy Picture
Table Product Specifications of Cancer Targeted Therapy
Table Global Cancer Targeted Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Targeted Therapy Revenue Market Share by Types in 2018
Figure Tumor Antigens As Targets of Antibodies Picture
Figure Development of Antibodies for Clinical Purposes Picture
Figure Complement Dependent Cytotoxicity (CDC) Picture
Figure Signal Transduction Changes Picture
Table Global Cancer Targeted Therapy Revenue (Million USD) by Application (2014-2024)
Figure Cancer Targeted Therapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Market Cancer Targeted Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Advaxis Basic Information, Manufacturing Base and Competitors
Table Advaxis Cancer Targeted Therapy Type and Applications
Table Advaxis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bind Therapeutics Basic Information, Manufacturing Base and Competitors
Table Bind Therapeutics Cancer Targeted Therapy Type and Applications
Table Bind Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Cancer Targeted Therapy Type and Applications
Table Boehringer Ingelheim Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol Mayer Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Mayer Squibb Cancer Targeted Therapy Type and Applications
Table Bristol Mayer Squibb Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table Celldex Therapeutics Cancer Targeted Therapy Type and Applications
Table Celldex Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table Dendreon Corporation Cancer Targeted Therapy Type and Applications
Table Dendreon Corporation Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lily Basic Information, Manufacturing Base and Competitors
Table Eli Lily Cancer Targeted Therapy Type and Applications
Table Eli Lily Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table GalaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GalaxoSmithKline Cancer Targeted Therapy Type and Applications
Table GalaxoSmithKline Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Galena Biopharma Basic Information, Manufacturing Base and Competitors
Table Galena Biopharma Cancer Targeted Therapy Type and Applications
Table Galena Biopharma Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Genetech Basic Information, Manufacturing Base and Competitors
Table Genetech Cancer Targeted Therapy Type and Applications
Table Genetech Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table ImmunoCellular Therapeutics Cancer Targeted Therapy Type and Applications
Table ImmunoCellular Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table ImmunoGen Basic Information, Manufacturing Base and Competitors
Table ImmunoGen Cancer Targeted Therapy Type and Applications
Table ImmunoGen Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Inovio Pharmaceuticals Cancer Targeted Therapy Type and Applications
Table Inovio Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Targeted Therapy Type and Applications
Table Johnson & Johnson Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NeoStem Oncology Basic Information, Manufacturing Base and Competitors
Table NeoStem Oncology Cancer Targeted Therapy Type and Applications
Table NeoStem Oncology Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NewLink Genetics Basic Information, Manufacturing Base and Competitors
Table NewLink Genetics Cancer Targeted Therapy Type and Applications
Table NewLink Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Northwest Biotherapeutics Cancer Targeted Therapy Type and Applications
Table Northwest Biotherapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Targeted Therapy Type and Applications
Table Merck Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Targeted Therapy Type and Applications
Table Novartis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Peregrine Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Peregrine Pharmaceuticals Cancer Targeted Therapy Type and Applications
Table Peregrine Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Targeted Therapy Type and Applications
Table Pfizer Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Targeted Therapy Type and Applications
Table Roche Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Targeted Therapy Type and Applications
Table Sanofi Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table Seattle Genetics Cancer Targeted Therapy Type and Applications
Table Seattle Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Targeted Therapy Type and Applications
Table Teva Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Targeted Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Targeted Therapy Revenue Share by Players (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Share by Players in 2017
Figure Global Cancer Targeted Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Targeted Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Targeted Therapy Revenue Market Share in 2018
Figure Global Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Targeted Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Targeted Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Market Share by Regions in 2018
Figure North America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure South America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table North America Cancer Targeted Therapy Revenue by Countries (2014-2019)
Table North America Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Targeted Therapy Revenue Market Share by Countries in 2018
Figure USA Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table Europe Cancer Targeted Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Targeted Therapy Revenue Market Share by Countries in 2018
Figure Germany Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure UK Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure France Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Targeted Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Targeted Therapy Revenue Market Share by Countries in 2018
Figure China Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure India Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table South America Cancer Targeted Therapy Revenue by Countries (2014-2019)
Table South America Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Targeted Therapy Revenue Market Share by Countries in 2018
Figure Brazil Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Targeted Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Targeted Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Targeted Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
Table Global Cancer Targeted Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Targeted Therapy Revenue Share by Type (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Share by Type (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Share by Type in 2019
Table Global Cancer Targeted Therapy Revenue Forecast by Type (2019-2024)
Figure Global Cancer Targeted Therapy Market Share Forecast by Type (2019-2024)
Figure Global Tumor Antigens As Targets of Antibodies Revenue Growth Rate (2014-2019)
Figure Global Development of Antibodies for Clinical Purposes Revenue Growth Rate (2014-2019)
Figure Global Complement Dependent Cytotoxicity (CDC) Revenue Growth Rate (2014-2019)
Figure Global Signal Transduction Changes Revenue Growth Rate (2014-2019)
Table Global Cancer Targeted Therapy Revenue by Application (2014-2019)
Table Global Cancer Targeted Therapy Revenue Share by Application (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Share by Application (2014-2019)
Figure Global Cancer Targeted Therapy Revenue Share by Application in 2019
Table Global Cancer Targeted Therapy Revenue Forecast by Application (2019-2024)
Figure Global Cancer Targeted Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Cancer Targeted Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Targeted Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Targeted Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
Figure Europe Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
Figure South America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
小分子標的癌療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…- 乳癌用HER-2標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global HER-2 Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- 乳癌VEGF標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global VEGF Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 乳癌用ER標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global ER Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 乳癌用標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…